The panel convened to assess if the current labels effectively explain the upsides and downsides of taking fluoroquinolones to treat sinus infections, urinary-tract infections (UTIs), and bronchitis that aggravates existing chronic obstructive pulmonary disease (COPD).
These antibiotics belong...